Intelligenome

About

IntelliGenome is a CRISPR molecular diagnostic start-up based in Houston, Texas. The company was founded in July 2022 with a commitment to commercialize an innovative CRISPR detection platform technology. Our mission is to revolutionize the field of disease diagnostics by harnessing the power of CRISPR technology. Our innovative platform enables direct measurement and quantification of active disease elements, providing healthcare providers with critical information for treatment monitoring and optimizing drug efficacy.​​

Founders

• Wilson Zhang — Co-founder and CEO
• Tony Hu — Founder and Chief Science Advisor

Partnerships

News

• IntelliGenome Receives INVIMA Approval for CRISPR-TB Blood Test and Appoints Velez Lab as Exclusive Distribution Partner in Colombia · 2026-06-29T12:31:00.000Z
• IntelliGenome Receives FDA Breakthrough Device Designation for CRISPR-TB Blood Test · 2025-01-21T13:47:00.000Z
• Intelligenome Announces R&D Subaward Agreement with Cornell University to Advance Rapid Point-of-Care Tuberculosis Diagnosis · 2026-03-23T12:41:00.000Z
• IntelliGenome Announces Strategic Partnership with CTR Scientific to Advance CRISPR-TB in Mexico · 2026-06-15T12:33:00.000Z
• IntelliGenome, CTR Scientific Partner for CRISPR... - GenomeWeb · 2026-06-15T00:00:00.000Z
• Intelligenome, Cornell to Develop Low-Cost Point-of-Care Tuberculosis Diagnostic | 360Dx · 2026-03-23T14:27:47.000Z

Browse related software

• Clinic software in TX
• Clinic software in Houston
• All clinic software companies A–Z